Cytosorbents
CTSO
#9856
Rank
A$64.66 M
Marketcap
A$1.03
Share price
-3.82%
Change (1 day)
-38.70%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -A$20.21 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$36.97 Million. In 2024 the company made an earning of -A$33.89 Million, an increase over its 2023 earnings that were of -A$43.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$20.21 Million-40.37%
2024 -A$33.89 Million-22.49%
2023 -A$43.72 Million-13.52%
2022 -A$50.55 Million34.04%
2021 -A$37.72 Million182.17%
2020 -A$13.37 Million-55.97%
2019 -A$30.36 Million14.17%
2018 -A$26.59 Million95.14%
2017 -A$13.63 Million-22.32%
2016 -A$17.54 Million39.1%
2015 -A$12.61 Million-12.89%
2014 -A$14.48 Million89%
2013 -A$7.66 Million26.65%
2012 -A$6.05 Million-26.02%
2011 -A$8.18 Million-288.45%
2010 A$4.33 M-4.17%
2009 A$4.52 M-287.19%
2008 -A$2.42 Million-47.12%
2007 -A$4.58 Million41.78%
2006 -A$3.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
A$82.75 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.19 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
A$4.87 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA